All stock lists
Stantec Inc (New York Stock Exchange:STN)
CA · Delayed Price · Currency is USD
Also listed: STN.TOIndustrials · Engineering & Construction
75.50-0.33 (-0.44%)
Market cap
$8.49B
Insider Score
Health Score
Analyst consensus
Listed since
Aug 5, 2005
Website
Insider Score
––Not scored
STN Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Sound
From STN’s reported statements · Q2 2026 (trailing 12 months)
Profitability13 / 20
Profitable, but on a thin margin.
- Revenue
- $8.11B
- Net income
- $505.2M
- Net margin
- 6.2%
Leverage10 / 20
A manageable debt load.
- Total debt
- $2.73B
- Cash
- $377.3M
- Net debt / EBITDA
- 2.03x
Liquidity13 / 20
Comfortably covers what is due within a year.
- Current assets
- $3.02B
- Current liabilities
- $2.01B
- Current ratio
- 1.50
Cash generation16 / 20
The business funds itself from operations.
- Operating cash flow
- $744.2M
- Free cash flow
- $665.9M
- FCF margin
- 8.2%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 113.6M
- Share growth (1y)
- -0.4%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
STN Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | $1.78 B | $2.07 B | $2.11 B | $2.14 B | $1.44 B | $1.92 B |
| Revenue Growth (YoY) | 23.41 % | 7.77 % | 7.89 % | 10.94 % | -23.65 % | 11.75 % |
| Cost of Revenue | $809.90 M | $1.25 B | $1.33 B | $1.21 B | $866.20 M | $1.08 B |
| Gross Profit | $970.70 M | $821.42 M | $788.76 M | $927.90 M | $576.58 M | $843.50 M |
| SG&A Expense | $648.20 M | $646.37 M | $604.71 M | $616.00 M | $440.77 M | $612.00 M |
| R&D Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $714.60 M | $646.37 M | $604.71 M | $706.00 M | $440.77 M | $690.50 M |
| Operating Income | $256.10 M | $175.05 M | $184.05 M | $221.90 M | $135.81 M | $153.00 M |
| Pretax Income | $200.10 M | $146.98 M | $122.00 M | $198.80 M | $131.55 M | $130.00 M |
| Tax Provision | $49.80 M | $35.89 M | $28.18 M | $48.80 M | $32.10 M | $29.90 M |
| Net Income | $150.30 M | $111.09 M | $93.82 M | $150.00 M | $99.45 M | $100.10 M |
| EPS (Basic) | $1.32 | $0.98 | $0.82 | $1.32 | $1.19 | $0.88 |
| EPS (Diluted) | $1.32 | $0.98 | $0.82 | $1.32 | $1.19 | $0.88 |
| Shares Outstanding | 113.56 M | 114.07 M | 114.07 M | 114.07 M | 114.07 M | 114.07 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.